Workplace Violence, Hostility & Safety

Status Withdrawn

Clinical Trial Summary

Workplace violence has been documented as a global, epidemic healthcare- related problem. The American Nurses Association (ANA) describes customer/client violence as an assault from a member of the public with whom the nurse interacts during the course of their regular duties. According to the ANA's website, types of violence that contribute to unsafe work environments are varying. However the customer/client violence type is prevalently experienced in healthcare, and 1 in 4 nurses are abused and experience workplace violence.

Clinical Trial Description

Based on anecdotal reports at MRMC, and as a follow up to a 2020 research study, evidence-based practice research council (EBPRC) members and staff asked colleagues about stress-producing events in their scope of work. It was reported that individuals were unclear about available resources and preparation to handle unsafe environments when client/visitor behaviors escalated to aggressive or unsafe situations. The EBPRC members reviewed the MRMC policies related to violence/assault/injury towards MRMC personnel. What remains unclear is if staff are aware of existing policies and are adhering to reporting guidelines pertaining to employee and stakeholder safety. Additionally, based on literature review, the problem of workplace violence perpetrated by patients and visitors is excessive and escalating nationally and internationally. Additionally, at MRMC, the EBPRC acquired documentation of the number of reported assaults, aggressive behavior or violence of stakeholders (patients and visitors) towards healthcare providers that were documented and referred to the MRMC employee health services. From the local hospital's tally, there were 28 cases from January, 10, 2020 to February 4, 2021. Of the 28 cases, seven occurred between February 2, 2021 and February 4, 2021. Hence, it is essential to conduct a study targeting healthcare workers at MRMC to identify opportunities for further intervention that creates a safety-focused, supportive culture. The Occupational Safety and Health Act and the Occupational Safety and Health Administration require that employees and employers work together to prevent or abate recognized hazardous and cited workplace areas for concerns and develop a successful safety and health management system especially for Healthcare and Social Services workers. ;

Study Design

Related Conditions & MeSH terms

Violence

Clinical Trial Details

NCT number	NCT05224752
Study type	Observational
Source	Methodist Health System
Contact
Status	Withdrawn
Phase
Start date	May 28, 2021
Completion date	December 31, 2022

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00729391` - Women-Focused HIV Prevention in the Western Cape	Phase 2/Phase 3
Recruiting	`NCT06062732` - Face It Evaluation	N/A
Withdrawn	`NCT03762356` - Questionnaire About Individual's Insight/Awareness of Risk of Violence
Completed	`NCT02506088` - Preventing Sexual Aggression Among High School Boys	N/A
Completed	`NCT02458365` - A Stage-Based Expert System for Teen Dating Violence Prevention	Phase 2
Completed	`NCT00251212` - Tailored Teen Alcohol and Violence Prevention in the Emergency Room (ER)	N/A
Completed	`NCT00527358` - Evaluation of SAFER Latinos' Program to Prevent Youth Violence	Phase 2/Phase 3
Completed	`NCT01025674` - Randomized Trial of the Positive Action Program in Chicago Schools and Extension to Grade 8	N/A
Completed	`NCT00164541` - An Arts-Based Initiative for the Prevention of Violence Against Women and Girls	Phase 1
Recruiting	`NCT05706376` - An Evidence-based Family Support Program for Parents and Children in Palestine: A Theory-based Intervention	N/A
Recruiting	`NCT06001554` - Preventing Physical and Emotional Violence by Teachers in Public Schools in Pakistan	N/A
Recruiting	`NCT05585918` - The R-CITY Project: A Collaborative Intervention With Teachers and Youth	N/A
Recruiting	`NCT06099262` - GenPMTO Evaluation
Recruiting	`NCT05595759` - Violence Against Women in Patients With Alcohol Substance Addiction Training	N/A
Completed	`NCT05207319` - Effects of Integrated Moral Reasoning Development Intervention for Management of Violence in Schizophrenia	N/A
Completed	`NCT03473067` - Community Level Primary Prevention of Dating and Sexual Violence in Middle Schools	N/A
Completed	`NCT06056661` - Within My Reach (WMR) Adaptation	N/A
Not yet recruiting	`NCT04520399` - Prediction of Violent Behavior in Patients With Schizophrenia by Multimodal Machine Learning
Not yet recruiting	`NCT02257944` - Assessing and Reducing Risk of Violent Re-Injury Among Victims of Urban Violence	N/A
Completed	`NCT01770873` - A Multi-Center Randomized Controlled Trial of Mentoring to Prevent Youth Violence	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.